1. Home
  2. RVSB vs ADVM Comparison

RVSB vs ADVM Comparison

Compare RVSB & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVSB
  • ADVM
  • Stock Information
  • Founded
  • RVSB 1923
  • ADVM 2006
  • Country
  • RVSB United States
  • ADVM United States
  • Employees
  • RVSB N/A
  • ADVM N/A
  • Industry
  • RVSB Savings Institutions
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RVSB Finance
  • ADVM Health Care
  • Exchange
  • RVSB Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • RVSB 115.1M
  • ADVM 119.6M
  • IPO Year
  • RVSB 1993
  • ADVM 2014
  • Fundamental
  • Price
  • RVSB $5.80
  • ADVM $5.13
  • Analyst Decision
  • RVSB
  • ADVM Strong Buy
  • Analyst Count
  • RVSB 0
  • ADVM 6
  • Target Price
  • RVSB N/A
  • ADVM $27.83
  • AVG Volume (30 Days)
  • RVSB 34.5K
  • ADVM 286.5K
  • Earning Date
  • RVSB 01-23-2025
  • ADVM 11-04-2024
  • Dividend Yield
  • RVSB 1.38%
  • ADVM N/A
  • EPS Growth
  • RVSB N/A
  • ADVM N/A
  • EPS
  • RVSB 0.05
  • ADVM N/A
  • Revenue
  • RVSB $46,297,000.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • RVSB N/A
  • ADVM N/A
  • Revenue Next Year
  • RVSB $12.50
  • ADVM N/A
  • P/E Ratio
  • RVSB $122.00
  • ADVM N/A
  • Revenue Growth
  • RVSB N/A
  • ADVM N/A
  • 52 Week Low
  • RVSB $3.30
  • ADVM $4.97
  • 52 Week High
  • RVSB $6.57
  • ADVM $29.70
  • Technical
  • Relative Strength Index (RSI)
  • RVSB 74.10
  • ADVM 31.23
  • Support Level
  • RVSB $5.56
  • ADVM $4.97
  • Resistance Level
  • RVSB $5.78
  • ADVM $6.07
  • Average True Range (ATR)
  • RVSB 0.12
  • ADVM 0.35
  • MACD
  • RVSB -0.00
  • ADVM -0.05
  • Stochastic Oscillator
  • RVSB 75.68
  • ADVM 14.93

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is an American savings and loan holding company. The company through its subsidiaries engages in the business of attracting deposits and puts it to use in its market area to originate commercial business. It is organized into two operating segments, Banking Operations performed by the bank and trust and Investment Services performed by the Trust company. The company products and services include checking, saving, money market, mortgage, home equity, consumer, online banking, cash management, and others.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Share on Social Networks: